Creo Medical Group (LSE:CREO) Institutional Ownership: 38.59% (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:CREO Creo Medical Group PLC LSE:CREO
52 GF Score
Price £0.14
GF Value £0.18
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Creo Medical Group Institutional Ownership?

Creo Medical Group LSE:CREO 52 Institutional Ownership is 38.59% as of Jul. 22, 2026. GuruFocus rates LSE:CREO with a GF Score™ of 52/100 and a GF Value™ of £0.18 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Creo Medical Group's institutional ownership is 38.59%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Creo Medical Group's Insider Ownership is 6.92%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Creo Medical Group's Float Percentage Of Total Shares Outstanding is 0.00%.

Creo Medical Group Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Creo Medical Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group Institutional Ownership Chart

Creo Medical Group Historical Data

The historical data trend for Creo Medical Group can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 39.80 45.26 45.13 43.91 44.03 44.21 44.04 44.06 38.10 38.59
LSE:CREO
52GF Score
Creo Medical Group PLC LSE:CREO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creo Medical Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 38.59% mean?
Creo Medical Group (LSE:CREO) has a Institutional Ownership of 38.59% as of Jul. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Creo Medical Group and its competitors.
Is Creo Medical Group's Institutional Ownership too high?
Creo Medical Group's current Institutional Ownership is 38.59%. Overall, Creo Medical Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Creo Medical Group's Institutional Ownership compare to ABT and SYK?
Creo Medical Group's Institutional Ownership of 38.59% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Creo Medical Group and its competitors. Creo Medical Group's current Institutional Ownership is 38.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creo Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Creo Medical Group (LSE:CREO) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.18, compared to a current price of £0.14 — trading 22.9% below its estimated fair value. The current Institutional Ownership is 38.59%. Creo Medical Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Creo Medical Group (LSE:CREO), the current Institutional Ownership is 38.59% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creo Medical Group (LSE:CREO) Overvalued in 2026?

Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued. The current stock price of £0.14 is trading 22.9% below its estimated GF Value™ of £0.18. GuruFocus considers Creo Medical Group to be Modestly Undervalued.

Key valuation signals for LSE:CREO:

  • Institutional Ownership: 38.59%
  • GF Value™: £0.18 vs. price of £0.14 (22.9% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the LSE:CREO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creo Medical Group Business Description

Address Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
52GF Score

Get the complete analysis for LSE:CREO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.14
Price
£0.18
GF Value